Bide Pharmatech Co., Ltd. (SHA:688073)

Bide Pharmatech Statistics

Total Valuation

Bide Pharmatech has a market cap or net worth of CNY 4.59 billion. The enterprise value is 3.68 billion.

Market Cap	4.59B
Enterprise Value	3.68B

Important Dates

The next confirmed earnings date is Thursday, April 23, 2026.

Earnings Date	Apr 23, 2026
Ex-Dividend Date	Jun 9, 2025

Share Statistics

Bide Pharmatech has 86.15 million shares outstanding. The number of shares has decreased by -2.23% in one year.

Current Share Class	86.15M
Shares Outstanding	86.15M
Shares Change (YoY)	-2.23%
Shares Change (QoQ)	-1.96%
Owned by Insiders (%)	51.61%
Owned by Institutions (%)	17.15%
Float	27.57M

Valuation Ratios

The trailing PE ratio is 30.45 and the forward PE ratio is 22.53.

PE Ratio	30.45
Forward PE	22.53
PS Ratio	3.47
PB Ratio	2.29
P/TBV Ratio	2.30
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	24.16
EV / Sales	2.78
EV / EBITDA	17.65
EV / EBIT	18.62
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.12
Debt / EBITDA	1.13
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 7.55% and return on invested capital (ROIC) is 14.08%.

Return on Equity (ROE)	7.55%
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	14.08%
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	7.66%
Revenue Per Employee	1.79M
Profits Per Employee	206,235
Employee Count	129
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Bide Pharmatech has paid 43.75 million in taxes.

Income Tax	43.75M
Effective Tax Rate	22.33%

Stock Price Statistics

The stock price has increased by +3.59% in the last 52 weeks. The beta is 0.69, so Bide Pharmatech's price volatility has been lower than the market average.

Beta (5Y)	0.69
52-Week Price Change	+3.59%
50-Day Moving Average	62.41
200-Day Moving Average	63.21
Relative Strength Index (RSI)	39.76
Average Volume (20 Days)	1,184,399

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Bide Pharmatech had revenue of CNY 1.32 billion and earned 152.20 million in profits. Earnings per share was 1.75.

Revenue	1.32B
Gross Profit	1.32B
Operating Income	197.50M
Pretax Income	195.96M
Net Income	152.20M
EBITDA	208.37M
EBIT	197.50M
Earnings Per Share (EPS)	1.75

Balance Sheet

The company has 1.15 billion in cash and 236.14 million in debt, with a net cash position of 913.03 million or 10.60 per share.

Cash & Cash Equivalents	1.15B
Total Debt	236.14M
Net Cash	913.03M
Net Cash Per Share	10.60
Equity (Book Value)	2.00B
Book Value Per Share	23.24
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Depreciation & Amortization	10.87M
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 100.00%, with operating and profit margins of 14.92% and 11.50%.

Gross Margin	100.00%
Operating Margin	14.92%
Pretax Margin	14.80%
Profit Margin	11.50%
EBITDA Margin	15.74%
EBIT Margin	14.92%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.90, which amounts to a dividend yield of 1.65%.

Dividend Per Share	0.90
Dividend Yield	1.65%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	2.23%
Shareholder Yield	3.81%
Earnings Yield	3.32%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on May 25, 2023. It was a forward split with a ratio of 1.4.

Last Split Date	May 25, 2023
Split Type	Forward
Split Ratio	1.4

Scores

Altman Z-Score	n/a
Piotroski F-Score	2